Skip to content

The effect of ketorolac in the treatment of shoulder impingement syndrome

Comparison the effect of Ketorolac sub acromial injection with methyl prednisolone in patient with shoulder impingement syndrome that refers to Isfahan university clinics in 2016-2017.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011231906N1
Enrollment
40
Registered
2017-02-20
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder impingment syndrom. Impingement syndrome of shoulder

Interventions

Intervention 1: Patient history, examination and shoulder X-ray (Ap & lat) will be produced. Before treatment, we use the VAS score for severity of pain and Constant Score for shoulder Range of motion
Treatment - Drugs
Patient history, examination and shoulder X-ray (Ap & lat) will be produced. Before treatment, we use the VAS score for severity of pain and Constant Score for shoulder Range of motion and function in

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. age between 20 to 80 years old; 2. shoulder pain with the following positive test: the internal rotation resistance test (Neer test) and the Hawkins-Kennedy test; 3. approved participation in the research project Exclusion criteria: 1. rheumatoid arthritis, osteoarthritis of the glenohumeral, complete tearing of the rotator cuff, shoulder girdle fracture, diabetes mellitus, infection and tumor; 2. change in treatment plan; 3. receiving subacromial injection from 8 weeks ago; 4. pregnant or plan to become pregnant; 5. there are risk factors for intra-articular injection, such as bleeding disorders or receiving anticoagulant; 6. contraindication for steroid injections / lidocaine and NSAID such as sensitivity to these drugs; 7. shoulder pain and dysfunction in the front side; 8. unavailability of patient after injection.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Admission, one and 3 months later. Method of measurement: Visual Analog Scale (VAS).;Function and range of motion. Timepoint: Admission, one and 3 months later. Method of measurement: Constant Shoulder Score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sahar Mousavi

Isfahan University of Medical Sciences

s.mousavi.md@gmail.com+98 913 300 2733

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026